General Information of This Drug (ID: DMLPEZS)

Drug Name
Venglustat   DMLPEZS
Synonyms
Ibiglustat; 1401090-53-6; UNII-BLP1XA3FZA; BLP1XA3FZA; (S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate; Ibiglustat [INN]; SCHEMBL12615329; YFHRCLAKZBDRHN-MRXNPFEDSA-N; Ibiglustat(Genz-682452 pound(c); GZ-452; SAR402671; ZINC202143443; AKOS027337125; CS-6512; Carbamic acid, N-(1-(2-(4-fluorophenyl)-4-thiazolyl)-1-methylethyl)-, (3S)-1-azabicyclo(2.2.2)oct-3-yl ester; (3S)-1-Azabicyclo(2.2.2)octan-3-yl N-(2-(2-(4-fluorophenyl)-1,3-thiazol-4-yl)propan-2-yl)carbamate; GZ4026
Indication
Disease Entry ICD 11 Status REF
Fabry disease 5C56.01 Phase 2 [1]
Parkinson disease 8A00.0 Phase 2 [2]
Gaucher disease 5C56.0Y Phase 1 [3]
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

18 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
AG-881 + Venglustat DC2L9IN AG-881 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
PFI-3 + Venglustat DC4AAVU PFI-3 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Tosyl-l-arginine methyl ester + Venglustat DCQYJNO Tosyl-l-arginine methyl ester Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Ribavirin-TP DC1VU1L Ribavirin-TP Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + PD-0325901 DCM5LVP PD-0325901 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + MK-1775 DCA9Q2J MK-1775 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + JQ1 DCMZKTD JQ1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Panobinostat DCS8CZS Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Everolimus DC92B6A Everolimus Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Evacetrapib DCV7D54 Evacetrapib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Marizomib DCEZZ29 Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + ONC201 DC1IM8K ONC201 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + LEE011 DCFJMGM LEE011 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + BMS-754807 DCBZ3WS BMS-754807 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Teriflunomide DCKC98B Teriflunomide Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + PF-562271 DCCPRQN PF-562271 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + THZ1 DCRLSFX THZ1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Venglustat + Ruxolitinib DCVIEW8 Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 18 DrugCom(s)

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036945)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.